SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-052428
Filing Date
2023-10-06
Accepted
2023-10-06 17:00:09
Documents
12
Period of Report
2023-10-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K tcon-20231002.htm   iXBRL 8-K 41689
  Complete submission text file 0000950170-23-052428.txt   154378

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcon-20231002_pre.xml EX-101.PRE 9461
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcon-20231002_lab.xml EX-101.LAB 12806
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcon-20231002.xsd EX-101.SCH 2481
6 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20231002_htm.xml XML 4550
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 342037594 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 231314793
SIC: 2836 Biological Products, (No Diagnostic Substances)